 | 240 | Name: | (2S)-2-(2-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID | Formula: | C28 H24 F3 N O6 | SMILES: | O=C(O)C(Oc1ccccc1Cc3c2cc(OC(F)(F)F)ccc2n(c3C)C(=O)c4ccc(OC)cc4)C | InChi: | InChI=1S/C28H24F3NO6/c1-16-22(14-19-6-4-5-7-25(19)37-17(2)27(34)35)23-15-21(38-28(29,30)31)12-13-24(23)32(16)26(33)18-8-10-20(36-3)11-9-18/h4-13,15,17H,14H2,1-3H3,(H,34,35)/t17-/m0/s1 | Synonyms: | MRL20 | Definition date: | 2007-06-15 | Last modified: | 2021-03-01 | Identifier: | (2S)-2-[2-({1-[(4-methoxyphenyl)carbonyl]-2-methyl-5-(trifluoromethoxy)-1H-indol-3-yl}methyl)phenoxy]propanoic acid |
|
 | 241 | Name: | (2S)-2-(3-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID | Formula: | C28 H24 F3 N O6 | SMILES: | O=C(O)C(Oc1cccc(c1)Cc3c2cc(OC(F)(F)F)ccc2n(c3C)C(=O)c4ccc(OC)cc4)C | InChi: | InChI=1S/C28H24F3NO6/c1-16-23(14-18-5-4-6-21(13-18)37-17(2)27(34)35)24-15-22(38-28(29,30)31)11-12-25(24)32(16)26(33)19-7-9-20(36-3)10-8-19/h4-13,15,17H,14H2,1-3H3,(H,34,35)/t17-/m0/s1 | Synonyms: | MRL24 | Definition date: | 2007-06-25 | Last modified: | 2021-03-01 | Identifier: | (2S)-2-[3-({1-[(4-methoxyphenyl)carbonyl]-2-methyl-5-(trifluoromethoxy)-1H-indol-3-yl}methyl)phenoxy]propanoic acid |
|
 | 242 | Name: | 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | Formula: | C23 H17 F3 N4 O | SMILES: | FC(F)(F)c1cccc(c1)NC(=O)c4cc(c3cc2c(nc(nc2)N)cc3)c(cc4)C | InChi: | InChI=1S/C23H17F3N4O/c1-13-5-6-15(21(31)29-18-4-2-3-17(11-18)23(24,25)26)10-19(13)14-7-8-20-16(9-14)12-28-22(27)30-20/h2-12H,1H3,(H,29,31)(H2,27,28,30) | Synonyms: | AMINOQUINAZOLINE 1 | Definition date: | 2007-01-09 | Last modified: | 2021-03-01 | Identifier: | 3-(2-aminoquinazolin-6-yl)-4-methyl-N-[3-(trifluoromethyl)phenyl]benzamide |
|
 | 256 | Name: | PHENYL(SULFO)ACETIC ACID | Formula: | C8 H8 O5 S | SMILES: | O=S(=O)(O)C(C(=O)O)c1ccccc1 | InChi: | InChI=1S/C8H8O5S/c9-8(10)7(14(11,12)13)6-4-2-1-3-5-6/h1-5,7H,(H,9,10)(H,11,12,13)/t7-/m1/s1 | Synonyms: | RU79256 | Definition date: | 2003-06-20 | Last modified: | 2021-03-01 | Identifier: | (2R)-phenyl(sulfo)ethanoic acid |
|
 | 25H | Name: | {2-[2-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)ethoxy]ethyl}phosphonic acid | Formula: | C9 H14 N5 O5 P | SMILES: | O=P(O)(O)CCOCCn1c2N=C(NC(=O)c2nc1)N | InChi: | InChI=1S/C9H14N5O5P/c10-9-12-7-6(8(15)13-9)11-5-14(7)1-2-19-3-4-20(16,17)18/h5H,1-4H2,(H2,16,17,18)(H3,10,12,13,15) | Synonyms: | 9-(2-phosphonoethoxyethyl)guanine | Definition date: | 2009-03-05 | Last modified: | 2021-03-01 | Identifier: | {2-[2-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)ethoxy]ethyl}phosphonic acid |
|
 | 25L | Name: | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate | Formula: | C30 H40 N15 O25 P5 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](O)(=O)O[CH]4[CH](O)[CH](CO[P](O)(=O)O[CH]5[CH](O)[CH](CO[P](O)(=O)O[P](O)(=O)O[P](O)(O)=O)O[CH]5n6cnc7c(N)ncnc67)O[CH]4n8cnc9c(N)ncnc89)[CH](O)[CH]3O | InChi: | InChI=1S/C30H40N15O25P5/c31-22-13-25(37-4-34-22)43(7-40-13)28-19(49)16(46)10(64-28)1-61-72(53,54)67-20-17(47)11(65-29(20)44-8-41-14-23(32)35-5-38-26(14)44)2-62-73(55,56)68-21-18(48)12(3-63-74(57,58)70-75(59,60)69-71(50,51)52)66-30(21)45-9-42-15-24(33)36-6-39-27(15)45/h4-12,16-21,28-30,46-49H,1-3H2,(H,53,54)(H,55,56)(H,57,58)(H,59,60)(H2,31,34,37)(H2,32,35,38)(H2,33,36,39)(H2,50,51,52)/t10-,11-,12-,16-,17-,18-,19-,20-,21-,28-,29-,30-/m1/s1 | Synonyms: | 2'-5'-oligoadenylate trimer | Definition date: | 2009-09-15 | Last modified: | 2021-03-01 | Release date: | 2014-02-05 | Identifier: | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate |
|
 | V6D | Name: | (3S,6Z,8E,11S,15R)-15-amino-3-[(1E,3E,5E)-7-(dimethylamino)-2,5-dimethylhepta-1,3,5-trien-1-yl]-9,11-dimethyl-4,12-dioxa-20-thia-21-azabicyclo[16.2.1]henicosa-1(21),6,8,18-tetraene-5,13-dione | Formula: | C30 H43 N3 O4 S | SMILES: | C1(=CC=CC(=O)OC(Cc2scc(CCC(N)CC(=O)OC(C1)C)n2)[C@H]=C(C)C=[C@H]C(C)=[C@H]CN(C)C)C | InChi: | InChI=1S/C30H43N3O4S/c1-21(14-15-33(5)6)10-11-23(3)17-27-19-28-32-26(20-38-28)13-12-25(31)18-30(35)36-24(4)16-22(2)8-7-9-29(34)37-27/h7-11,14,17,20,24-25,27H,12-13,15-16,18-19,31H2,1-6H3/b9-7-,11-10+,21-14+,22-8+,23-17+/t24-,25+,27+/m0/s1 | Synonyms: | des-methyl Pateamine A | Definition date: | 2020-07-07 | Last modified: | 2021-03-01 | Release date: | 2021-01-06 | Identifier: | (3S,6Z,8E,11S,15R)-15-amino-3-[(1E,3E,5E)-7-(dimethylamino)-2,5-dimethylhepta-1,3,5-trien-1-yl]-9,11-dimethyl-4,12-dioxa-20-thia-21-azabicyclo[16.2.1]henicosa-1(21),6,8,18-tetraene-5,13-dione |
|
 | HBN | Name: | N-(2-NAPHTHYL)HISTIDINAMIDE | Formula: | C16 H16 N4 O | SMILES: | O=C(Nc2cc1ccccc1cc2)C(N)Cc3cncn3 | InChi: | InChI=1S/C16H16N4O/c17-15(8-14-9-18-10-19-14)16(21)20-13-6-5-11-3-1-2-4-12(11)7-13/h1-7,9-10,15H,8,17H2,(H,18,19)(H,20,21)/t15-/m1/s1 | Synonyms: | L-HISTIDINE BETA NAPHTHYLAMIDE | Definition date: | 2004-04-05 | Last modified: | 2021-03-01 | Identifier: | N-naphthalen-2-yl-D-histidinamide |
|
 | HBV | Name: | 3-fluoro-N-hydroxy-4-[(methyl{[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]decan-1-yl]methyl}amino)methyl]benzamide | Formula: | C20 H27 F N2 O2 | SMILES: | C(C13CC2CC(C1)CC(C2)C3)N(C)Cc4c(F)cc(C(=O)NO)cc4 | InChi: | InChI=1S/C20H27FN2O2/c1-23(11-17-3-2-16(7-18(17)21)19(24)22-25)12-20-8-13-4-14(9-20)6-15(5-13)10-20/h2-3,7,13-15,25H,4-6,8-12H2,1H3,(H,22,24)/t13-,14+,15-,20- | Synonyms: | Bavarostat | Definition date: | 2018-06-25 | Last modified: | 2021-03-01 | Release date: | 2018-08-29 | Identifier: | 3-fluoro-N-hydroxy-4-[(methyl{[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]decan-1-yl]methyl}amino)methyl]benzamide |
|
 | HBY | Name: | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY-3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN-2(1H)-THIONE | Formula: | C15 H20 N2 O3 S2 | SMILES: | S=C2Nc1c(cc(OC)cc1)N(C(=O)OC(C)C)C2CSC | InChi: | InChI=1S/C15H20N2O3S2/c1-9(2)20-15(18)17-12-7-10(19-3)5-6-11(12)16-14(21)13(17)8-22-4/h5-7,9,13H,8H2,1-4H3,(H,16,21)/t13-/m0/s1 | Synonyms: | HBY 097 | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | 1-methylethyl (2S)-7-methoxy-2-[(methylsulfanyl)methyl]-3-thioxo-3,4-dihydroquinoxaline-1(2H)-carboxylate |
|
 | HC5 | Name: | (R)-3-CARBOXY-2-(HEXANOYLOXY)-N,N,N-TRIMETHYLPROPAN-1-AMINIUM | Formula: | C13 H26 N O4 | SMILES: | O=C(O)CC(OC(=O)CCCCC)C[N+](C)(C)C | InChi: | InChI=1S/C13H25NO4/c1-5-6-7-8-13(17)18-11(9-12(15)16)10-14(2,3)4/h11H,5-10H2,1-4H3/p+1/t11-/m1/s1 | Synonyms: | HEXANOYLCARNITINE | Definition date: | 2006-05-26 | Last modified: | 2021-03-01 | Identifier: | (2R)-3-carboxy-2-(hexanoyloxy)-N,N,N-trimethylpropan-1-aminium |
|
 | HCD | Name: | (3alpha,8alpha)-cholest-5-ene-3,20-diol | Formula: | C27 H46 O2 | SMILES: | OC(C4C3(C(C1C(C2(C(=CC1)CC(O)CC2)C)CC3)CC4)C)(C)CCCC(C)C | InChi: | InChI=1S/C27H46O2/c1-18(2)7-6-14-27(5,29)24-11-10-22-21-9-8-19-17-20(28)12-15-25(19,3)23(21)13-16-26(22,24)4/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t20-,21-,22-,23-,24-,25-,26-,27-/m0/s1 | Synonyms: | 20S-hydroxycholesterol | Definition date: | 2010-06-02 | Last modified: | 2021-03-01 | Identifier: | (3alpha,8alpha)-cholest-5-ene-3,20-diol |
|
 | 274 | Name: | (3Z)-N-(3-CHLOROPHENYL)-3-({3,5-DIMETHYL-4-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]-1H-PYRROL-2-YL}METHYLENE)-N-METHYL-2-OXOINDOLINE-5-SULFONAMIDE | Formula: | C28 H30 Cl N5 O4 S | SMILES: | O=C(N1CCN(C)CC1)c5c(c(/C=C3/c2cc(ccc2NC3=O)S(=O)(=O)N(c4cccc(Cl)c4)C)nc5C)C | InChi: | InChI=1S/C28H30ClN5O4S/c1-17-25(30-18(2)26(17)28(36)34-12-10-32(3)11-13-34)16-23-22-15-21(8-9-24(22)31-27(23)35)39(37,38)33(4)20-7-5-6-19(29)14-20/h5-9,14-16,30H,10-13H2,1-4H3,(H,31,35)/b23-16- | Synonyms: | MET KINASE INHIBITOR | Definition date: | 2006-10-17 | Last modified: | 2021-03-01 | Identifier: | (3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylidene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide |
|
 | HCE | Name: | {(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-hydroxypyrrolidin-3-yl}-L-methionine | Formula: | C16 H24 N6 O3 S | SMILES: | O=C(O)C(N)CCSCC3CN(Cc2cnc1c2ncnc1N)CC3O | InChi: | InChI=1S/C16H24N6O3S/c17-11(16(24)25)1-2-26-7-10-5-22(6-12(10)23)4-9-3-19-14-13(9)20-8-21-15(14)18/h3,8,10-12,19,23H,1-2,4-7,17H2,(H,24,25)(H2,18,20,21)/t10-,11+,12+/m1/s1 | Synonyms: | homocysteine-DADMe-Immucillin-A | Definition date: | 2012-05-11 | Last modified: | 2021-03-01 | Release date: | 2013-05-01 | Identifier: | {(3S,4R)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-hydroxypyrrolidin-3-yl}-L-methionine |
|
 | HCM | Name: | (2S)-2-amino-4-(methyldisulfanyl)butanoic acid | Formula: | C5 H11 N O2 S2 | SMILES: | O=C(O)C(N)CCSSC | InChi: | InChI=1S/C5H11NO2S2/c1-9-10-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 | Synonyms: | S-methylsulfanyl-homocystein | Definition date: | 2012-12-18 | Last modified: | 2021-03-01 | Release date: | 2013-12-18 | Identifier: | (2S)-2-amino-4-(methyldisulfanyl)butanoic acid |
|
 | HCY | Name: | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione | Formula: | C21 H30 O5 | SMILES: | O=C(CO)C3(O)C2(CC(O)C4C1(C(=CC(=O)CC1)CCC4C2CC3)C)C | InChi: | InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 | Synonyms: | CORTISOL | Definition date: | 2007-10-13 | Last modified: | 2021-03-01 | Identifier: | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione |
|
 | 27R | Name: | [2-amino-3-(4-bromobenzoyl)phenyl]acetic acid | Formula: | C15 H12 Br N O3 | SMILES: | O=C(c1ccc(Br)cc1)c2cccc(c2N)CC(=O)O | InChi: | InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19) | Synonyms: | Bromfenac | Definition date: | 2013-09-05 | Last modified: | 2021-03-01 | Release date: | 2013-09-18 | Identifier: | [2-amino-3-(4-bromobenzoyl)phenyl]acetic acid |
|
 | HDC | Name: | 3R-HYDROXYDECANOYL-COENZYME A | Formula: | C31 H54 N7 O18 P3 S | SMILES: | O=C(SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP(=O)(O)O)CC(O)CCCCCCC | InChi: | InChI=1S/C31H54N7O18P3S/c1-4-5-6-7-8-9-19(39)14-22(41)60-13-12-33-21(40)10-11-34-29(44)26(43)31(2,3)16-53-59(50,51)56-58(48,49)52-15-20-25(55-57(45,46)47)24(42)30(54-20)38-18-37-23-27(32)35-17-36-28(23)38/h17-20,24-26,30,39,42-43H,4-16H2,1-3H3,(H,33,40)(H,34,44)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/t19-,20-,24-,25-,26+,30-/m1/s1 | Synonyms: | 3R-HYDROXYDECANOYL-COA | Definition date: | 2003-06-17 | Last modified: | 2021-03-01 | Identifier: | S-{(9R,13S,15R)-17-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-9,13,15-trihydroxy-10,10-dimethyl-13,15-dioxido-4,8-dioxo-12,14,16-trioxa-3,7-diaza-13,15-diphosphaheptadec-1-yl} (3R)-3-hydroxydecanethioate (non-preferred name) |
|
 | HDG | Name: | (2R,5S)-2-amino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-5-[(benzylamino)methyl]-N-[2-(4-methoxyphenyl)ethyl]hexanamide (non-preferred name) | Formula: | C32 H42 N8 O5 | SMILES: | C(CNCc1ccccc1)(CC2C(O)C(C(O2)n3cnc4c3ncnc4N)O)CCC(C(=O)NCCc5ccc(OC)cc5)N | InChi: | InChI=1S/C32H42N8O5/c1-44-23-10-7-20(8-11-23)13-14-36-31(43)24(33)12-9-22(17-35-16-21-5-3-2-4-6-21)15-25-27(41)28(42)32(45-25)40-19-39-26-29(34)37-18-38-30(26)40/h2-8,10-11,18-19,22,24-25,27-28,32,35,41-42H,9,12-17,33H2,1H3,(H,36,43)(H2,34,37,38)/t22-,24+,25+,27+,28+,32+/m0/s1 | Synonyms: | (R)-SKI-72 | Definition date: | 2018-06-26 | Last modified: | 2021-03-01 | Release date: | 2018-07-25 | Identifier: | (2R,5S)-2-amino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-5-[(benzylamino)methyl]-N-[2-(4-methoxyphenyl)ethyl]hexanamide (non-preferred name) |
|
 | HDL | Name: | D-arabinohydroxamic acid | Formula: | C5 H9 N O7 | SMILES: | O=C(NO)C(O)C(O)C(O)C(=O)O | InChi: | InChI=1S/C5H9NO7/c7-1(3(9)5(11)12)2(8)4(10)6-13/h1-3,7-9,13H,(H,6,10)(H,11,12)/t1-,2+,3+/m1/s1 | Synonyms: | D-arabinohydroxamate | Definition date: | 2009-05-26 | Last modified: | 2021-03-01 | Identifier: | 1-(hydroxyamino)-D-lyxuronic acid |
|
 | 28S | Name: | 6-bromo-N-(prop-2-en-1-yl)quinazolin-4-amine | Formula: | C11 H10 Br N3 | SMILES: | Brc2cc1c(ncnc1NCC=C)cc2 | InChi: | InChI=1S/C11H10BrN3/c1-2-5-13-11-9-6-8(12)3-4-10(9)14-7-15-11/h2-4,6-7H,1,5H2,(H,13,14,15) | Synonyms: | SMER28 | Definition date: | 2011-07-12 | Last modified: | 2021-03-01 | Identifier: | 6-bromo-N-(prop-2-en-1-yl)quinazolin-4-amine |
|
 | HEJ | Name: | 9-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-9H-purin-6-amine | Formula: | C10 H16 N5 O13 P3 | SMILES: | Nc1ncnc2c1ncn2C3OC(COP(O)(=O)OP(O)(=O)OP(O)(=O)O)C(O)C3O | InChi: | InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7+,10-/m1/s1 | Synonyms: | Vidarabine-TRIPHOSPHATE | Definition date: | 2018-06-27 | Last modified: | 2021-03-01 | Release date: | 2018-10-24 | Identifier: | 9-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-9H-purin-6-amine |
|
 | HF4 | Name: | 4-amino-1-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}pyrimidin-2(1H)-one | Formula: | C9 H16 N3 O14 P3 | SMILES: | C=1N(C(=O)N=C(N)C=1)C2C(C(C(COP(OP(OP(=O)(O)O)(O)=O)(O)=O)O2)O)O | InChi: | InChI=1S/C9H16N3O14P3/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7+,8-/m1/s1 | Synonyms: | Cytarabine-TRIPHOSPHATE | Definition date: | 2018-06-27 | Last modified: | 2021-03-01 | Release date: | 2018-10-10 | Identifier: | 4-amino-1-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}pyrimidin-2(1H)-one |
|
 | HF7 | Name: | 2'-deoxy-2-methyladenosine 5'-(tetrahydrogen triphosphate) | Formula: | C11 H18 N5 O12 P3 | SMILES: | c3(nc(c2c(n(C1CC(C(COP(=O)(O)OP(OP(O)(O)=O)(=O)O)O1)O)cn2)n3)N)C | InChi: | InChI=1S/C11H18N5O12P3/c1-5-14-10(12)9-11(15-5)16(4-13-9)8-2-6(17)7(26-8)3-25-30(21,22)28-31(23,24)27-29(18,19)20/h4,6-8,17H,2-3H2,1H3,(H,21,22)(H,23,24)(H2,12,14,15)(H2,18,19,20)/t6-,7+,8+/m0/s1 | Synonyms: | Cladribine-TRIPHOSPHATE | Definition date: | 2018-06-27 | Last modified: | 2021-03-01 | Release date: | 2018-10-10 | Identifier: | 2'-deoxy-2-methyladenosine 5'-(tetrahydrogen triphosphate) |
|
 | HFG | Name: | 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one | Formula: | C16 H17 Br Cl N3 O3 | SMILES: | Brc3c(Cl)cc1c(N=CN(C1=O)CC(=O)CC2NCCCC2O)c3 | InChi: | InChI=1S/C16H17BrClN3O3/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14/h5-6,8,14-15,19,23H,1-4,7H2/t14-,15+/m1/s1 | Synonyms: | Halofuginone | Definition date: | 2012-11-09 | Last modified: | 2021-03-01 | Release date: | 2012-12-28 | Identifier: | 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one |
|